Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

COSRX Launches The Alpha-Arbutin 2 Skin Discoloration Serum


News provided by

COSRX

13 Jan, 2025, 03:52 GMT

Share this article

Share toX

Share this article

Share toX

The Ultimate Solution for Blemish and Hyperpigmentation Care

LONDON, Jan. 13, 2025 /PRNewswire/ -- Viral K-Beauty brand, COSRX introduces a powerful new solution to blemish care with The Alpha-Arbutin 2 Skin Discoloration Serum, now available on Amazon. This innovative formula blends a powerful mix of ingredients to enhance spot improvement and promote faster healing. Designed to soothe and hydrate irritated skin, it quickly absorbs for a refreshing, non-sticky feel. Suitable for all skin types, this gentle serum effectively addresses various blemish concerns without causing irritation, promising a clearer, more radiant complexion.

Continue Reading
This image opens in the lightbox
The Ultimate Solution for Blemish and Hyperpigmentation Care, now available at Amazon.
This image opens in the lightbox

What makes The Alpha-Arbutin 2 Skin Discoloration Serum exceptional is its powerful blend of five active ingredients, each playing a critical role in targeting skin discoloration to synergistically inhibit melanin production, reduce post-inflammatory hyperpigmentation (PIH), and fade unwanted dark spots. PIH refers to the dark marks left behind after acne or skin irritation, but this serum goes beyond facial concerns, offering a solution for all types of discoloration across the body.

Core Ingredients That Do It All:

  • Alpha Arbutin: Prevents melanin synthesis, halting discoloration at its source.
  • Tranexamic Acid: Suppresses melanin synthesis, helping to reduce existing spots.
  • Niacinamide: Inhibits melanin transfer to the skin's surface, preventing dark spots.
  • N-Acetyl Glucosamine (NAG): Exfoliates discolored dead skin cells, promoting brighter skin.
  • Ferulic Acid & Glutathione: Target all stages of hyperpigmentation for comprehensive prevention and care.
  • Soothing and Hydration: To soothe irritation and maintain hydration, the serum is enriched with Madecassoside, Tocopherol (Vitamin E), Panthenol, Hyaluronic Acid, and Allantoin. These ingredients not only calm the skin but also support overall skin health and barrier function.

Unlike many other serums, The Alpha-Arbutin 2 Skin Discoloration Serum is gentle enough for sensitive skin, having been clinically tested for low irritation. It doesn't sting upon application and is non-comedogenic, making it a perfect choice for acne-prone skin. Its lightweight and fast-absorbing texture ensures a non-sticky, refreshing experience suitable for all skin types and climates.

With a combination of potent actives and ingredients like niacinamide and five types of hyaluronic acid, this serum not only tackles discoloration but also enhances skin texture and hydration, setting it apart from typical offerings on the market. As the demand for effective and gentle skincare solutions continues to rise, The Alpha-Arbutin 2 Skin Discoloration Serum offers a reliable option for individuals looking to enhance their skin's health and appearance.

The Alpha-Arbutin 2 Skin Discoloration Serum is now available at Amazon for $25.

About COSRX: With its powerful yet affordable skincare solutions, COSRX has quickly become one of America's favorite skincare brands. Using a minimal number of highly effective natural extracts in concentrated doses, COSRX products deliver visible results by treating the skin with only the essentials it needs and nothing it doesn't. Find its best-selling skincare solutions at retailers nationwide, including Amazon, Boosts, Lookfantastic, and TikTok UK store.

  • Instagram: https://www.instagram.com/cosrx
  • TikTok: https://www.tiktok.com/@cosrx_uk
  • COSRX Official Website: https://www.cosrx.com

Photo - https://mma.prnewswire.com/media/2596205/The_Ultimate_Solution_Blemish_Hyperpigmentation_Care_Amazon.jpg
Photo - https://mma.prnewswire.com/media/2596206/The_Ultimate_Solution_Blemish_Hyperpigmentation_Care_Amazon_1.jpg

Modal title

Also from this source

COSRX and YesStyle Conclude Record-Breaking Euro Supporters Recruitment, 100 Influencers Selected from Across Europe

COSRX and YesStyle Conclude Record-Breaking Euro Supporters Recruitment, 100 Influencers Selected from Across Europe

Global K-Beauty leader COSRX, in partnership with YesStyle, has officially closed recruitment for its first-ever Euro Supporters program, a...

K-Beauty Pioneer COSRX Launches first-ever 'Euro Supporters' Program in Collaboration with YESSTYLE to Expand Global Footprint

K-Beauty Pioneer COSRX Launches first-ever 'Euro Supporters' Program in Collaboration with YESSTYLE to Expand Global Footprint

COSRX, the global K-Beauty brand known for its effective yet gentle skincare solutions, has announced the launch of its first-ever Euro Supporters...

More Releases From This Source

Explore

Retail

Retail

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Health Care & Hospitals

Health Care & Hospitals

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.